Literature DB >> 18492743

Respiratory muscle unloading improves leg muscle oxygenation during exercise in patients with COPD.

A Borghi-Silva1, C C Oliveira, C Carrascosa, J Maia, D C Berton, F Queiroga, E M Ferreira, D R Almeida, L E Nery, J A Neder.   

Abstract

BACKGROUND: Respiratory muscle unloading during exercise could improve locomotor muscle oxygenation by increasing oxygen delivery (higher cardiac output and/or arterial oxygen content) in patients with chronic obstructive pulmonary disease (COPD).
METHODS: Sixteen non-hypoxaemic men (forced expiratory volume in 1 s 42.2 (13.9)% predicted) undertook, on different days, two constant work rate (70-80% peak) exercise tests receiving proportional assisted ventilation (PAV) or sham ventilation. Relative changes (Delta%) in deoxyhaemoglobin (HHb), oxyhaemoglobin (O(2)Hb), tissue oxygenation index (TOI) and total haemoglobin (Hb(tot)) in the vastus lateralis muscle were measured by near-infrared spectroscopy. In order to estimate oxygen delivery (Do(2)est, l/min), cardiac output and oxygen saturation (Spo(2)) were continuously monitored by impedance cardiography and pulse oximetry, respectively.
RESULTS: Exercise tolerance (Tlim) and oxygen uptake were increased with PAV compared with sham ventilation. In contrast, end-exercise blood lactate/Tlim and leg effort/Tlim ratios were lower with PAV (p<0.05). There were no between-treatment differences in cardiac output and Spo(2) either at submaximal exercise or at Tlim (ie, Do(2)est remained unchanged with PAV; p>0.05). Leg muscle oxygenation, however, was significantly enhanced with PAV as the exercise-related decrease in Delta(O(2)Hb)% was lessened and TOI was improved; moreover, Delta(Hb(tot))%, an index of local blood volume, was increased compared with sham ventilation (p<0.01).
CONCLUSIONS: Respiratory muscle unloading during high-intensity exercise can improve peripheral muscle oxygenation despite unaltered systemic Do(2 )in patients with advanced COPD. These findings might indicate that a fraction of the available cardiac output had been redirected from ventilatory to appendicular muscles as a consequence of respiratory muscle unloading.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18492743     DOI: 10.1136/thx.2007.090167

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  30 in total

1.  Expiratory muscle loading increases intercostal muscle blood flow during leg exercise in healthy humans.

Authors:  Dimitris Athanasopoulos; Zafeiris Louvaris; Evgenia Cherouveim; Vasilis Andrianopoulos; Charis Roussos; Spyros Zakynthinos; Ioannis Vogiatzis
Journal:  J Appl Physiol (1985)       Date:  2010-05-27

2.  Impact of pulmonary system limitations on locomotor muscle fatigue in patients with COPD.

Authors:  Markus Amann; Mark S Regan; Majd Kobitary; Marlowe W Eldridge; Urs Boutellier; David F Pegelow; Jerome A Dempsey
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05-05       Impact factor: 3.619

3.  Performance difference on the six-minute walk test on tracks of 20 and 30 meters for patients with chronic obstructive pulmonary disease: validity and reliability.

Authors:  Suelen Roberta Klein; Aline Almeida Gulart; Raysa Silva Venâncio; Anelise Bauer Munari; Simone Graciosa Gavenda; Ana Carolina Benedet Martins; Anamaria Fleig Mayer
Journal:  Braz J Phys Ther       Date:  2020-01-22       Impact factor: 3.377

4.  High oxygen extraction and slow recovery of muscle deoxygenation kinetics after neuromuscular electrical stimulation in COPD patients.

Authors:  Diego de Paiva Azevedo; Wladimir Musetti Medeiros; Flávia Fernandes Manfredi de Freitas; Cesar Ferreira Amorim; Ana Cristina Oliveira Gimenes; Jose Alberto Neder; Luciana Dias Chiavegato
Journal:  Eur J Appl Physiol       Date:  2016-07-28       Impact factor: 3.078

5.  The impact of thoracic load carriage up to 45 kg on the cardiopulmonary response to exercise.

Authors:  Devin B Phillips; Cameron M Ehnes; Michael K Stickland; Stewart R Petersen
Journal:  Eur J Appl Physiol       Date:  2016-07-09       Impact factor: 3.078

6.  Impact of Non-Invasive Ventilation on Sympathetic Nerve Activity in Chronic Obstructive Pulmonary Disease.

Authors:  Helge Haarmann; Jan Folle; Xuan Phuc Nguyen; Peter Herrmann; Karsten Heusser; Gerd Hasenfuß; Stefan Andreas; Tobias Raupach
Journal:  Lung       Date:  2016-11-16       Impact factor: 2.584

7.  Influence of respiratory pressure support on hemodynamics and exercise tolerance in patients with COPD.

Authors:  Cristino Carneiro Oliveira; Cláudia Regina Carrascosa; Audrey Borghi-Silva; Danilo C Berton; Fernando Queiroga; Eloara M V Ferreira; Luiz E Nery; J Alberto Neder; J Alberto Neder
Journal:  Eur J Appl Physiol       Date:  2010-03-06       Impact factor: 3.078

Review 8.  An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  François Maltais; Marc Decramer; Richard Casaburi; Esther Barreiro; Yan Burelle; Richard Debigaré; P N Richard Dekhuijzen; Frits Franssen; Ghislaine Gayan-Ramirez; Joaquim Gea; Harry R Gosker; Rik Gosselink; Maurice Hayot; Sabah N A Hussain; Wim Janssens; Micheal I Polkey; Josep Roca; Didier Saey; Annemie M W J Schols; Martijn A Spruit; Michael Steiner; Tanja Taivassalo; Thierry Troosters; Ioannis Vogiatzis; Peter D Wagner
Journal:  Am J Respir Crit Care Med       Date:  2014-05-01       Impact factor: 21.405

9.  Deep breathing heart rate variability is associated with respiratory muscle weakness in patients with chronic obstructive pulmonary disease.

Authors:  Michel Silva Reis; Ross Arena; Ana Paula Deus; Rodrigo Polaquini Simões; Aparecida Maria Catai; Audrey Borghi-Silva
Journal:  Clinics (Sao Paulo)       Date:  2010-04       Impact factor: 2.365

10.  Bronchodilator effect on ventilatory, pulmonary gas exchange, and heart rate kinetics during high-intensity exercise in COPD.

Authors:  Pierantonio Laveneziana; Paolo Palange; Josuel Ora; Dario Martolini; Denis E O'Donnell
Journal:  Eur J Appl Physiol       Date:  2009-08-27       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.